Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
Seiderer J, Brand S, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T. Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study. Aliment Pharmacol Ther 2007; 25:787-96.
01.04.2007
Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
01.04.2007
Aliment Pharmacol Ther 2007; 25:787-96
Seiderer J, Brand Stephan, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T
Weiter
